GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Helix BioPharma Corp (TSX:HBP) » Definitions » 3-Year EPS without NRI Growth Rate

Helix BioPharma (TSX:HBP) 3-Year EPS without NRI Growth Rate : 24.60% (As of Jan. 2024)


View and export this data going back to 1996. Start your Free Trial

What is Helix BioPharma 3-Year EPS without NRI Growth Rate?

Helix BioPharma's EPS without NRI for the three months ended in Jan. 2024 was C$-0.00.

During the past 3 years, the average EPS without NRI Growth Rate was 24.60% per year. During the past 5 years, the average EPS without NRI Growth Rate was 18.50% per year. During the past 10 years, the average EPS without NRI Growth Rate was 12.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Helix BioPharma was 24.60% per year. The lowest was -3.90% per year. And the median was 13.15% per year.


Competitive Comparison of Helix BioPharma's 3-Year EPS without NRI Growth Rate

For the Biotechnology subindustry, Helix BioPharma's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Helix BioPharma's 3-Year EPS without NRI Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Helix BioPharma's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Helix BioPharma's 3-Year EPS without NRI Growth Rate falls into.



Helix BioPharma 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


Helix BioPharma  (TSX:HBP) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


Helix BioPharma 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Helix BioPharma's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Helix BioPharma (TSX:HBP) Business Description

Industry
Traded in Other Exchanges
Address
401 Bay Street, Suite 2704, Toronto, ON, CAN, M5H 2Y
Helix BioPharma Corp is a clinical-stage biopharmaceutical company. It is focused on cancer drug development. The company develops therapies in the field of immuno-oncology based on its proprietary technology mainly in the areas of cancer prevention and treatment. Its pipeline candidates are Tumor Defence Breaker L-DOS47, and, V-DOS47 among others.

Helix BioPharma (TSX:HBP) Headlines

From GuruFocus